doi: 10.1136/bmj.1.5948.12-a.
I alpha-hydroxycholecalciferol: a treatment of renal bone disease
- PMID: 1120218
- PMCID: PMC1671878
- DOI: 10.1136/bmj.1.5948.12-a
Item in Clipboard
I alpha-hydroxycholecalciferol: a treatment of renal bone disease
Br Med J.
.
Abstract
Three patients with chronic renal failure on maintenance haemodialysis have been treated with 1 alpha-hydroxycholecalciferol (1 alpha-OHCC), a synthetic vitamin D analogue. A daily dose of 2 mug by mouth produced a significant increase in both calcium absorption from the gastrointestinal tract and calcium content of bone. Treatment with 1 alpha-OHCC appears to be effective in cases of metabolic bone disease associated with chronic renal failure.
Similar articles
-
Curative effects of 1alpha-hydroxycholecalciferol on calcium metabolism and bone disease in patients with chronic renal failure.J Nutr Sci Vitaminol (Tokyo). 1975;21(4):277-85. doi: 10.3177/jnsv.21.277. J Nutr Sci Vitaminol (Tokyo). 1975. PMID: 1214180
-
Treatment of uremic bone disease. Action of 5,6-trans-25-hydroxycholecalciferol (a vitamin D-analog) in chronic renal failure.Klin Wochenschr. 1973 Oct 1;51(19):979-81. doi: 10.1007/BF01468254. Klin Wochenschr. 1973. PMID: 4762587 No abstract available.
-
Disorders of calcium and bone metabolism in chronic renal failure.Mod Treat. 1970 May;7(3):675-85. Mod Treat. 1970. PMID: 4920810 Review. No abstract available.
-
Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.Lancet. 1974 Mar 9;1(7854):379-84. doi: 10.1016/s0140-6736(74)93149-3. Lancet. 1974. PMID: 4131033 No abstract available.
-
[Calcium metabolism disorder in chronic renal failure].Saishin Igaku. 1970 Feb 10;5(2):315-25. Saishin Igaku. 1970. PMID: 4908907 Review. Japanese. No abstract available.
Cited by
-
Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.J Clin Invest. 1976 Jun;57(6):1540-7. doi: 10.1172/JCI108424. J Clin Invest. 1976. PMID: 932193 Free PMC article.
-
1alpha-Hydroxycholecalciferol in children with renal osteodystrophy.Calcif Tissue Res. 1977 May;22 Suppl:371-5. doi: 10.1007/BF02064103. Calcif Tissue Res. 1977. PMID: 912549 No abstract available.
-
Renal bone disease.J R Coll Physicians Lond. 1976 Oct;11(1):75-85. J R Coll Physicians Lond. 1976. PMID: 789876 Free PMC article. Review. No abstract available.
-
Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.Arch Dis Child. 1977 Jun;52(6):473-81. doi: 10.1136/adc.52.6.473. Arch Dis Child. 1977. PMID: 879833 Free PMC article.
-
Studies on the mode of action of vitamin D XXXVII 1 alpha-hydroxyvitamin D3: a long-acting 1,25-dihydroxyvitamin D3 analog.Calcif Tissue Int. 1983 May;35(3):372-5. doi: 10.1007/BF02405061. Calcif Tissue Int. 1983. PMID: 6307498 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources